LAMEA Automated Liquid Handling Market Size to register a growth of 9.5% CAGR

20-11-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report LAMEA Automated Liquid Handling Market, published by KBV research, the LAMEA Automated Liquid Handling Market would witness market growth of 9.5% CAGR during the forecast period (2018 – 2024).

The Biotechnology & Pharmaceutical Companies market dominated the LAMEA Automated Liquid Handling Market by End User 2017, thereby, achieving a market value of $50.3 million by 2024,. The Contract Research Organizations market is expected to witness a CAGR of 10.6% during (2018 - 2024). Additionally, The Academic & Government Research Institutes market is expected to witness highest CAGR of 10% during (2018 - 2024).

The Brazil market would dominate the LAMEA High-Throughput Screening Automated Liquid Handling Market by 2024, growing at a CAGR of 7.9 % during the forecast period. The Argentina market is expected to witness a CAGR of 9.5% during (2018 - 2024). Additionally, The UAE market is expected to witness a CAGR of 8.3% during (2018 - 2024).

The Disposable Tips market dominated the Saudi Arabia Automated Liquid Handling Market by Modality 2017, growing at a CAGR of 9.5 % during the forecast period. The Fixed Tips market is expected to witness a CAGR of 10.4% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/lamea-automated-liquid-handling-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Illumina, Inc., Thermo Fisher Scientific, Inc., Abcam Plc., Epizyme, Inc., Agilent Technologies, Qiagen N.V., Merck & Co., (Merck), Active Motif, Diagenode, Inc. and Zymo Research Corporation (Zymo)